Cytek Biosciences (NASDAQ: CTKB) has announced that it will be unveiling its third quarter financial results on Tuesday 5th November 2024. This announcement is set to occur after market close, allowing investors and analysts to gain valuable insights into the company's performance during the quarter.
Wall Street financial experts are forecasting that the organization will announce an expected $0.01 loss per share for the quarter. Moreover, the firm is anticipated to disclose a total revenue of $50.7 million for this specific period.
The earnings report for the corresponding quarter of the prior year unveiled a per-share loss of $0.05. This was a direct result of the company's total revenue, which amounted to an impressive $48 million during that specific period.
The forecasts for the company's annual performance have been disclosed by Wall Street analysts, with an estimated total revenue of $203.94 million. In addition, they anticipate the company to report loss of $0.09 per share for the fiscal year.
Additionally, The company will host a conference call with investors and analysts on 5th November 2024 at 04:30 PM eastern time to review the Q3 2024 financial results.
During Friday's trading, Cytek Biosciences (CTKB) shares reached a low of $4.97 and a high of $5.23, along with a total volume of 745.00 thousand shares. The stock ended the regular trading session at $5.11, marking a rise of 3.23 percent.
